CytoDyn Inc. Increase (Decrease) in Inventories
CytoDyn Inc. (CYDY) reported Increase (Decrease) in Inventories of -$2.06 million for the 12-month period ending 2022-05-31, per its 10-K filed 2023-09-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2023-09-14
- CytoDyn Inc. increase (decrease) in inventories for the quarter ending 2022-05-31 was -$165.00K, a 224.06% decline year-over-year.
- CytoDyn Inc. increase (decrease) in inventories for the quarter ending 2022-02-28 was -$330.00K.
- CytoDyn Inc. increase (decrease) in inventories for the quarter ending 2021-11-30 was -$775.00K, a 101.71% decline year-over-year.
- CytoDyn Inc. increase (decrease) in inventories for the quarter ending 2021-08-31 was -$790.00K, a 102.01% decline year-over-year.
- CytoDyn Inc. increase (decrease) in inventories for fiscal 2022 was -$2.06M, a 102.60% decline from fiscal 2021.
- CytoDyn Inc. increase (decrease) in inventories for fiscal 2021 was $79.36M, a 314.47% increase from fiscal 2020.
- CytoDyn Inc. increase (decrease) in inventories for fiscal 2020 was $19.15M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-05-31 | -$165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-14 | -$495.00K derived: sum of 2 quarters · filed 2023-09-14 | -$1.27M derived: sum of 3 quarters · filed 2023-09-14 | -$2.06M 10-K · filed 2023-09-14 | |||
| 2022-02-28 | -$330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-11 | -$1.10M derived: sum of 2 quarters · filed 2022-04-11 | -$1.90M 10-Q · filed 2022-04-11 | -$1.76M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-11-30 | -$775.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | -$1.56M 10-Q · filed 2022-01-10 | -$1.43M derived: sum of 3 quarters · filed 2022-08-15 | -$6.96M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-08-31 | -$790.00K 10-Q · filed 2021-10-12 | -$657.00K derived: sum of 2 quarters · filed 2022-08-15 | -$6.19M derived: sum of 3 quarters · filed 2022-08-15 | $39.24M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-05-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-15 | -$5.40M derived: sum of 2 quarters · filed 2022-08-15 | $40.03M derived: sum of 3 quarters · filed 2022-08-15 | $79.36M 10-K · filed 2022-08-15 | $74.33M 10-K · filed 2021-07-30 | ||
| 2021-02-28 | -$5.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-11 | $39.90M derived: sum of 2 quarters · filed 2022-04-11 | $79.23M 10-Q · filed 2022-04-11 | $74.39M 10-Q · filed 2021-04-14 | $82.48M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2020-11-30 | $45.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $84.76M 10-Q · filed 2022-01-10 | $79.92M 10-Q · filed 2021-01-08 | $88.01M derived: sum of 3 quarters · filed 2022-08-15 | |||
| 2020-08-31 | $39.33M 10-Q · filed 2021-10-12 | $42.58M derived: sum of 2 quarters · filed 2022-08-15 | |||||
| 2020-05-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-15 | $19.15M 10-K · filed 2022-08-15 | $19.15M 10-K · filed 2020-08-14 | ||||
| 2020-02-29 | $15.90M 10-Q · filed 2021-04-14 | $15.90M 10-Q · filed 2020-04-09 |